Why Does Food Taste Bad During Treatment? How Cancer Medications Alter Taste Perception

Nausea, hair loss, and fatigue are well-known side effects of cancer treatment. However, a side effect that quietly erodes patients' lives and is often overlooked is "taste disorders." Suddenly, food tastes bland. Sweet things no longer taste sweet. Foods they once loved now seem unpleasant. These changes are not just a matter of dissatisfaction with meals. They lead to decreased appetite, weight loss, deterioration of nutritional status, and the loss of time spent at the table with family and friends. The study reported this time delves quite deeply into the "why" of this issue.

Introduced on April 21, 2026, this study suggests that cabozantinib, a type of tyrosine kinase inhibitor (TKI), may not reduce the number of taste buds themselves but rather alter the ratio of cells working within the taste buds. The research team verified this using mouse models and cultured taste tissues, confirming that after drug administration, the cells that sense sweetness decreased, while those related to bitterness and umami increased. Furthermore, the mice lost their preference for sweet solutions. In other words, the problem was not that the "tongue is broken," but that the "balance of cells that sense taste is skewed."

The key to this study was a protein called KIT. TKIs are primarily used to suppress pathways involved in cancer growth and tumor blood vessel formation, but in the process, they may inadvertently inhibit KIT. The research team believes that KIT plays an important role in the development and maintenance of taste cells. When KIT does not function properly, cells responsible for sweetness do not develop adequately, and the vacant space is filled by cells related to bitterness and umami. As a result, patients may feel as if the "map of their entire taste" has been rewritten, rather than just "sweetness disappearing."

What is important here is that the possibility has increased that this change is neither the patient's imagination nor merely a secondary effect of loss of appetite. According to the research institution's announcement, 10-50% of patients using TKIs experience taste changes. Although the numbers vary widely, indicating differences in symptoms depending on the type of treatment drug and patient background, it is not an uncommon side effect. Moreover, taste disorders are often treated lightly as "non-life-threatening side effects," but in reality, they can affect the continuation of treatment through decreased food intake and weight loss. A co-author and oncologist explained that patients may become unable to eat, lose weight, and as a result, need to reduce dosage or pause medication.

This point is consistent with existing reviews dealing with taste disorders associated with cancer treatment. Taste disorders have been said to not only make meals less enjoyable but also impact nutrition intake, quality of life (QOL), depressive tendencies, and social isolation. The value of this study lies in inserting a specific biological mechanism of changes in cell fate within taste buds into the background of such clinically significant issues. When the explanation of side effects remains vague, patients are prone to thinking they have no choice but to endure. However, if the cause is visible, there is room to consider avoidance or protective measures.

However, there are points to be cautiously observed at this stage. The main experimental systems in this study were mice and cultured taste tissues, and it has not been definitively concluded that the exact same thing happens in humans. The research team itself states that future confirmation in patients and exploration of methods to prevent or mitigate taste changes are necessary. Nevertheless, it provides a fairly convincing path to explaining patients' complaints. At the very least, a much more concrete answer has emerged to the question, "Why do only sweet things feel particularly strange?"

Interestingly, the content of this study seems to resonate significantly with the experiences of patients on social media. In reactions that could be confirmed within the public domain, sharing as a scientific news item was done on Reddit's r/science, and more vivid personal experiences were accumulated in its vicinity and patient communities. In one post, a voice described ice cream tasting "like soap" while taking cabozantinib, and another post mentioned "loss of taste, decreased appetite, and about a 40-pound weight loss." Another patient recalled, "The surface of my tongue felt like it was peeling, and nothing tasted good."

More impressively, the way symptoms manifest is not simply "no taste." Reports such as "sweet things disappear," "only bitterness stands out," "the smell is more distressing," and "the difference between what can and cannot be eaten is extreme" are mixed. In one post, taste decline due to cabozantinib was said to fluctuate according to a "5-day medication, 2-day pause" cycle, and in another family member's post, it was noted that during the pause week, food finally tasted "properly delicious," and weight stabilized. The explanation provided by this study, that "the ratio of cells within taste buds is skewed," is suggestive in understanding such complex and fluctuating complaints.

Observing reactions on social media, it becomes clear that taste disorders cannot be captured merely as a list of side effects. Eating is not only a means of nutrition but also a comfort, a pleasure, and the rhythm of life itself. One patient wrote that eating was an important way to care for themselves, and being deprived of it led to deep depression. The mention in the research presentation that patients may become isolated from meals with family and friends and that it could lead to depression is not an exaggeration. Here, the language of science and the words of patients point to the same place.

The implications of this study for future treatment are significant. One is the design of more selective drugs that can avoid affecting KIT, which is necessary for maintaining taste. Another is auxiliary interventions to protect the homeostasis of taste cells and taste buds. While specific measures are yet to be developed, the idea of treating taste as a therapeutic target to be protected, rather than dismissing it as "just a side effect," is likely to gain strength. Advances in cancer treatment are beginning to address not only extending survival time but also improving the quality of everyday life, such as whether patients can return to the dining table. This study should be read as a report indicating that turning point.

Source URL

Phys.org
https://phys.org/news/2026-04-cancer-drugs-disrupt-cells-buds.html

Press release by the research institution (Official announcement from CU Anschutz. Confirmation of research content, clinical significance, and future challenges)
https://news.cuanschutz.edu/news-stories/some-cancer-drugs-disrupt-taste-by-changing-the-cells-inside-taste-buds-study-shows

Original paper (Published in Development. Study showing the mechanism of KIT inhibition and changes in taste cell subtypes)
https://journals.biologists.com/dev/article/153/8/dev205259/371395/Tyrosine-kinase-inhibitors-affect-sweet-taste-and

Review on the clinical impact of taste disorders (Organizing the impact of taste disorders on QOL and nutrition, focusing on lung cancer patients)
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.774081/full

Review of oral side effects associated with cancer treatment (Confirming the positioning of oral toxicity and taste disorders in immunotherapy and molecular targeted therapy)
https://www.sciencedirect.com/science/article/pii/S2772906025000123

Sharing of scientific news on SNS (Confirmation of being a topic on r/science)
https://www.reddit.com/r/science/comments/1srpohf/researchers_at_the_university_of_colorado/

Patient experience story 1 on SNS (Reactions such as taste being "soapy" with cabozantinib)
https://www.reddit.com/r/cancer/comments/14j3o76/cabozantinib_taste_issues/

Patient experience story 2 on SNS (Experiencing side effects such as loss of taste and weight loss)
https://www.reddit.com/r/cancer/comments/9ak3tz/cabozantinib_side_effects/

Patient experience story 3 on SNS (The pain of losing the enjoyment of eating, "nothing tastes good")
https://www.reddit.com/r/cancer/comments/18vfnnq/i_miss_food/

Patient family experience story 4 on SNS (Description of taste and appetite returning during the pause week, stabilizing weight)
https://www.reddit.com/r/thyroidcancer/comments/1l7mvan/concerned_sister/